Published in Mol Neurobiol on October 28, 2016
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature (2011) 6.40
The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) (1987) 5.35
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc (2007) 4.51
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci (2001) 4.12
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci (2005) 3.77
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol (2007) 3.32
Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry (2005) 3.28
Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr (2000) 3.19
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18
A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol (2006) 2.90
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry (2007) 2.84
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 2.79
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45
Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med (2010) 2.40
Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev (2008) 2.30
Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08
BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry (2005) 2.00
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.91
Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res (2001) 1.89
Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87
Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect (2002) 1.81
Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology (1997) 1.73
A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res (1988) 1.70
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol (2012) 1.64
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol (2012) 1.62
Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem (1987) 1.58
Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol (2006) 1.57
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A (2008) 1.54
Immune-neural connections: how the immune system's response to infectious agents influences behavior. J Exp Biol (2013) 1.48
Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci (2005) 1.45
Ca2+ signals and neuronal death in brain ischemia. Stroke (2007) 1.45
Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis (2010) 1.39
Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes (2010) 1.37
Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem (2005) 1.26
The 'hidden' burden of malaria: cognitive impairment following infection. Malar J (2010) 1.23
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis (2008) 1.16
Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol (2007) 1.15
Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience (2009) 1.13
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia (2008) 1.10
A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. PLoS One (2010) 1.10
IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem (2013) 1.07
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain. Antimicrob Agents Chemother (2011) 1.06
Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J (2004) 1.06
The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem (2007) 1.04
Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol Ther (2011) 1.03
Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali. Malar J (2009) 1.01
CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers (2011) 1.00
Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Microbes Infect (2010) 1.00
Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats. Neurobiol Aging (2007) 0.99
Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry (2008) 0.98
NGF is essential for hippocampal plasticity and learning. J Neurosci (2009) 0.96
The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res (2006) 0.96
MK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma. BMC Neurosci (2011) 0.96
Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors. Methods Mol Biol (2012) 0.95
Glutamate released by Japanese encephalitis virus-infected microglia involves TNF-α signaling and contributes to neuronal death. Glia (2011) 0.94
CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. J Leukoc Biol (2008) 0.94
Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: effects on brain cytokines and neurotrophins. Exp Neurol (2010) 0.93
Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol (2000) 0.93
Delayed neuropsychiatric effects of malaria in Ghana. J Nerv Ment Dis (1998) 0.91
Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. J Mol Neurosci (2000) 0.89
The role of TNF-α, IL-6, IL-10, and GDNF in neuronal apoptosis in neonatal rat with hypoxic-ischemic encephalopathy. Eur Rev Med Pharmacol Sci (2014) 0.87
Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations. Neuropharmacology (2012) 0.87
Homeostatic control of synaptic transmission by distinct glutamate receptors. Neuron (2013) 0.86
Neuropsychiatric sequelae of cerebral malaria in Vietnam veterans. J Nerv Ment Dis (1997) 0.86
Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic Clin Pharmacol Toxicol (2007) 0.86
Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol Med (2008) 0.86
N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats. Pharmacol Biochem Behav (2011) 0.85
Rat cortical synaptosomes have more than one mechanism for Ca2+ entry linked to rapid glutamate release: studies using the Phoneutria nigriventer toxin PhTX2 and potassium depolarization. Biochem J (1993) 0.85
Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex. Neuropharmacology (2012) 0.84
Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide. Mol Cell Neurosci (2011) 0.84
The mechanism of memory impairment induced by Aβ chronic administration involves imbalance between cytokines and neurotrophins in the rat hippocampus. Curr Alzheimer Res (2011) 0.84
Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain. Exp Neurol (2010) 0.84
Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus. Exp Ther Med (2013) 0.84
Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA). Neurosci Lett (2011) 0.83
Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice. Exp Parasitol (2010) 0.82
Increased levels of glutamate in the central nervous system are associated with behavioral symptoms in experimental malaria. Braz J Med Biol Res (2010) 0.82
Effects of experimental cerebral malaria in memory, brain-derived neurotrophic factor and acetylcholinesterase activity [correction for acitivity] in the hippocampus of survivor mice. Neurosci Lett (2012) 0.80
Depressive-like-behavior and proinflamatory interleukine levels in the brain of rats submitted to pneumococcal meningitis. Brain Res Bull (2010) 0.80
Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection. Infect Immun (2014) 0.80
Brain metabolic markers reflect susceptibility status in cytokine gene knockout mice with murine cerebral malaria. Int J Parasitol (2006) 0.80
Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS One (2012) 0.79
Brain-derived neurotrophic factor and the course of experimental cerebral malaria. Brain Res (2012) 0.78
Imaging of small-animal models of infectious diseases. Am J Pathol (2012) 0.77
Effects of age and gender on the expression of brain-derived neurotrophic factor mRNA in rat retrosplenial cortex following administration of dizocilpine. Neuropsychopharmacology (2001) 0.77
Evidence for the contribution of adult neurogenesis and hippocampal cell death in experimental cerebral malaria cognitive outcome. Neuroscience (2014) 0.76
Activation of ionotropic glutamate receptors reduces the production of transforming growth factor-beta2 by developing neurons. Eur J Neurosci (2000) 0.75
Acute low dose of MK-801 prevents memory deficits without altering hippocampal DARPP-32 expression and BDNF levels in sepsis survivor rats. J Neuroimmunol (2010) 0.75
Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi. Malar J (2016) 0.75